Showing 1,781 - 1,800 results of 2,333 for search '(((((( terms increase ) OR ( five decrease ))) OR ( peer decrease ))) OR ( mean decrease ))*', query time: 0.17s Refine Results
  1. 1781
  2. 1782
  3. 1783
  4. 1784
  5. 1785

    Reply to Comments by Kakkar and Dahiya by Chahine, Elias B.

    Published 2014
    “…TO THE EDITOR: Chahine, Karaoui, and Mansour1 reviewed the efficacy and safety of bedaquiline in the treatment of adults with pulmonary multidrug-resistant tuberculosis (MDR-TB) and generally agree with the comments made by Kakkar and Dahiya.2 Bedaquiline was approved by the Food and Drug Administration based largely on results from phase 2 studies using sputum conversion as a surrogate marker for efficacy rather than long-term mortality data.2 Bedaquiline was shown to be associated with an unfavorable side effect profile, including an unexplained increased risk of mortality, QT prolongation, and elevated liver function tests.2 However, it is important to acknowledge that bedaquiline is the first novel drug to be approved for the treatment of TB in more than 4 decades and the communities devastated by MDR-TB are in desperate need for more options to manage their patients. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  6. 1786
  7. 1787
  8. 1788
  9. 1789
  10. 1790
  11. 1791
  12. 1792
  13. 1793
  14. 1794

    Climate change dynamics for global energy security and equity: Evidence from policy stringency drivers by Dagar, Vishal

    Published 2024
    “…The findings reveal that increased financial integration significantly enhances ES by easing capital flow into energy infrastructure, which is crucial for stable energy supply chains. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  15. 1795
  16. 1796
  17. 1797
  18. 1798
  19. 1799
  20. 1800